Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Photo of Jeff Hargroves
Individual Investor

Jeff Hargroves

Overview

Edit Overview Section
Number of Portfolio Companies 1
Number of Exits 
Unlock for free
  • Investor Type 
    obfuscation
  • Number of Exits 
    obfuscation
Jeff Hargroves is based out of Overland Park, Kansasand is the Board of Director of Cingulate Therapeutics. Jeff previously worked at Elixell Therapeutics as a Board Member. Jeff Hargroves attended the University of Missouri.

Personal Investments

Edit Personal Investments Section
Number of Investments 1
Jeff Hargroves invested in Cingulate Therapeutics on
obfuscation
. This investment - Post-IPO Equity - Cingulate Therapeutics - was valued at
obfuscation
.
Announced Date  
Organization Name  
Lead Investor  
Funding Round  
Money Raised  
obfuscation
Cingulate Therapeutics Logo
Cingulate Therapeutics
—
Post-IPO Equity - Cingulate Therapeutics Logo
Post-IPO Equity - Cingulate Therapeutics
obfuscation

Exits

Edit Exits Section
Number of Exits 
Unlock for free
Jeff Hargroves has
obfuscation
exit - Cingulate Therapeutics. Jeff Hargroves has
obfuscation
exits. Their most notable exits are Cingulate Therapeutics.
  • Cingulate Therapeutics Logo
    Cingulate Therapeutics Cingulate Therapeutics uses a unique combination of delivery technology and proven medications that creates an unmatched release profile.

Jobs

Edit Jobs Section
Number of Past Jobs 1
Jeff Hargroves has had 1 past job as the Founder, Board Member at ProPharma Group.
Organization Name  
Title At Company  
Start Date  
End Date  
ProPharma Group Logo
ProPharma Group
Founder, Board MemberMay 20182020

Board and Advisor Roles

Edit Board and Advisor Roles Section
Number of Current Board & Advisor Roles 3
Number of Past Board & Advisor Roles 1
Jeff Hargroves holds 3 board and advisor roles including Board of Director at Cingulate Therapeutics, Advisory Board Member at RS2 Healthcare Partners, and Advisor at Play-it Health.
Organization Name  
Title At Company  
Start Date  
End Date  
Elixell Therapeutics Logo
Elixell Therapeutics
Board Member2019Dec 2022

Education

Edit Education Section
Jeff Hargroves studied at University of Missouri.

Recent News and Activity

Edit Recent News and Activity Section
Funding Round•Feb 17, 2026
Cingulate Therapeutics raised
obfuscation
from Falcon Creek Capital Advisor and Jeff Hargroves
Discover more funding rounds
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(ccb7a32 1)
|